Appendix 2. Manual search for trial results outside of EUCTR.

Background:
Our paper on sponsors' compliance with EU rules requiring results to be reported onto EU Clinical Trials Register (EUCTR) within 12 months of completion found substantial noncompliance: of 7,274 trials required to report results onto EUCTR, only 3,601 (49.5%) did so. Our study reports compliance with EU reporting rules, and development of a tool to report compliance automatically on an ongoing basis. BMJ editors requested that we conduct a one-off manual search of journals and grey literature for a sample of unreported trials, to assess whether trials breaching EU trial reporting guidelines had reported results elsewhere.
Methods:
We manually searched for academic journal or grey literature results reports on a randomly selected sample of 100 trials from the 3,673 trials that breached EU reporting guidelines. Searches took place between 18 Jan 2018 and 12 Feb 2018. We searched for trial results on PubMed, Google Scholar and Google using trial ID and trial keywords, either alone or in combination as appropriate, including PI name and affiliation (if listed), sponsor, trial title, intervention and/or condition. We additionally examined entries on ClinicalTrials.gov, matched by trial ID or other study information, for supplementary information or posted results.
For analysis of publication delays, we took the difference between the earliest publication date out of all located results from the latest available completion date on EUCTR; for any publication dates prior to the latest completion date, delays were set to 0 days. Data on termination status and sponsor status for all trials in the sample were retrieved from the full EUCTR dataset.
All data is shared on Github at https://github.com/ebmdatalab/euctr-tracker-data.
Results:
Of 100 trials that breached EU rules and failed to report results on EUCTR, 51 had results available elsewhere: 46 in an academic journal publication; 5 in grey literature (3 in conference abstract; 1 in a press release; 1 in a company's clinical study report synopsis). 49 had no results identifiable anywhere. 19 trials in the sample were terminated in all countries: such trials are required to report results under both EU rules and US legislation. Of these, 2 reported results elsewhere (10.5%). Of trials with commercial sponsors (n=36), 38.9% reported results elsewhere compared to 57.6% for those with non-commercial sponsors (n=64). Median delay from trial completion to results being available in a journal publication or grey literature was 575 days (IQR 404-1091.5, range 0-2862).
